Table 2. CSF and routine laboratory analysis for the representative study group analyzed in the present study.
| Standard value | Study group | |||||
|---|---|---|---|---|---|---|
| N | Mean | SD* | CV* | Median | ||
| Proteins [mg/L] | 200–400 | 12 | 424.6 | 106.9 | 25.2% | 413.5 |
| White blood cell count [cells/mm3] | 0–4 | 12 | 0.4 | 0.6 | 151.9% | 0.0 |
| Erythrocyte count [cells/mm3] | 0–10 | 12 | 4.9 | 13.3 | 271.8% | 0.0 |
| CSF albumin [mg/L] | 0.0–350.0 | 12 | 276.2 | 77.3 | 28.0% | 255.5 |
| Serum albumin [g/L] | 35.00–55.00 | 12 | 42.7 | 2.6 | 6.1% | 42.8 |
| Albumin Quotient [ratio] | < 8 | 12 | 6.5 | 1.8 | 27.4% | 6.2 |
| CSF IgG [mg/L] | 10.0–40.0 | 12 | 29.4 | 8.0 | 27.4% | 30.5 |
| Serum IgG [g/L] | 8.0–18.0 | 12 | 10.0 | 1.8 | 18.2% | 9.7 |
| IgG Quotient [ratio] | ~ 2,3 | 12 | 3.0 | 0.9 | 29.4% | 2.8 |
| CSF IgA [mg/L] | 1.5–6.0 | 12 | 5.3 | 2.9 | 55.3% | 4.6 |
| Serum IgA [g/L] | 0.9–4.5 | 12 | 3.4 | 1.6 | 46.2% | 3.1 |
| IgA Quotient [ratio] | ~ 1,3 | 12 | 1.5 | 0.6 | 39.9% | 1.4 |
| CSF IgM [mg/L] | 0.0–1.0 | 12 | 0.2 | 0.1 | 37.5% | 0.2 |
| Serum IgM [g/L] | 0.6–2.5 | 12 | 1.0 | 0.5 | 48.0% | 0.8 |
| IgM Quotient [ratio] | ~ 0.3 | 12 | 0.3 | 0.3 | 82.7% | 0.2 |
Clinical CSF parameters (e.g., red and white blood cell count and protein concentrations) were determined to ensure a healthy study group. In addition CSF/serum quotients were determined.
*SD = standard deviation, CV = coefficent of variation.